Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Brattea
company
About
Brattea is a medical device research and development company.
- 11 - 50
Highlights
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $20M
- Industries
- Health Care,Health Diagnostics,Medical,Medical Device
- Founded date
- Jan 1, 2013
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Brattea is a medical device research and development company. Brattea focuses on the development and commercialization of renal denervation products with indications in hypertension, cancer pain and diabetes.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$20M
Brattea has raised a total of
$20M
in funding over 2 rounds. Their latest funding was raised on
Dec 22, 2022 from a Series C round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 22, 2022 | Series C | — | 1 |
Fosun International
|
— | Detail |
| Apr 6, 2021 | Series B | $20M | 1 |
Kuanping Capital
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
2
2
Brattea is funded by 2 investors.
Fosun International
and Kuanping Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Fosun International
|
Yes | Series C |
|
Kuanping Capital
|
Yes | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
